|
The International Society of Pharmacogenomics (ISP) has been established to bring together investigators worldwide in this emerging new field that integrates the latest advances in genomics to clinical pharmacology and therapeutics. The International Society of Pharmacogenomics is an independent body without any affiliation to institutions, and without direct institutional/administrative ties to any companies.
It was established in 2001 as a non-profit society to promote research into Pharmacogenomics: the influence of the human genome on response to medication. Pharmacogenomics searches for markers of drug response (such as DNA polymorphisms or gene expression changes), related to drug target, drug metabolism, or disease. It uses genomic technologies such as gene expression analysis, molecular genetics and transgenics. It encompasses both clinical response as well as adverse side effects and other physiological changes and can be applied to drugs in development as well as those in current use.
The International Society of Pharmacogenomics is a cross-disciplinary group of scientists/investigators who cover the fields of Pharmacogenomics with special efforts on science as well as outreach (policy and education). The ISP covers issues that are of broad interest and that cut across various fields and disciplines.
|
|
|
|
|
The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications. Publishing six times a year, the journal aims to provide the highest caliber of coverage concerning the effects of genetic variablity on drug toxicity and efficacy, the characterization of polymorphisms relevant to drug action, and the identification of novel genomic targets for drug development.
The Pharmacogenomics Journal is the official journal of the International Society of Pharmacogenomics (ISP). Members of the ISP receive a personal subscription as part of their membership.
|
|
|
|
|
Individual and corporate annual memberships are available. For further information regarding corporate memberships and the benefits, please email membership@pharmacogenomicsociety.org.
» www.pharmacogenomicsociety.org
Membership Levels & Costs:
» Academic and Government Affiliation
$250.00 USD (£140 | €200)
» Industry/Private Sector Affiliation
$350.00 USD (£195 | €285)
As a bonus of membership, all members will receive a subscription to The Pharmacogenomics Journal for the duration of their annual membership. Members will also have the possibility to set up or participate in scientific workgroups and help shape the Pharmacogenomics sector globally.
Please click here to go to the online form to begin the membership process.
|
|
|
